AR098825A1 - PHARMACEUTICAL OR COSMETIC COMPOSITIONS FOR TOPICAL USE THAT INCLUDE OCTENIDINE DIHYDROCLORIDE - Google Patents

PHARMACEUTICAL OR COSMETIC COMPOSITIONS FOR TOPICAL USE THAT INCLUDE OCTENIDINE DIHYDROCLORIDE

Info

Publication number
AR098825A1
AR098825A1 ARP140104753A ARP140104753A AR098825A1 AR 098825 A1 AR098825 A1 AR 098825A1 AR P140104753 A ARP140104753 A AR P140104753A AR P140104753 A ARP140104753 A AR P140104753A AR 098825 A1 AR098825 A1 AR 098825A1
Authority
AR
Argentina
Prior art keywords
weight
composition
glycol
skin
pharmaceutical
Prior art date
Application number
ARP140104753A
Other languages
Spanish (es)
Inventor
Trommer Hagen
Strahinjic Ivana
Willers Christoph
Mallwitz Henning
Evers Dirk
Original Assignee
Almirall Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Almirall Sa filed Critical Almirall Sa
Publication of AR098825A1 publication Critical patent/AR098825A1/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0014Skin, i.e. galenical aspects of topical compositions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4427Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
    • A61K31/444Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a six-membered ring with nitrogen as a ring heteroatom, e.g. amrinone
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A61K8/4906Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with one nitrogen as the only hetero atom
    • A61K8/4926Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with one nitrogen as the only hetero atom having six membered rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/10Dispersions; Emulsions
    • A61K9/107Emulsions ; Emulsion preconcentrates; Micelles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00Preparations for care of the skin
    • A61Q19/007Preparations for dry skin

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Dermatology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Dispersion Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Birds (AREA)
  • Medicinal Preparation (AREA)
  • Cosmetics (AREA)

Abstract

Se describen composiciones farmacéuticas o cosméticas para use tópico que comprenden dihidrocloruro de octenidina. Dichas composiciones son estables y se pueden aplicar de modo fácil y seguro sobre zonas extensas de la piel con buena aceptación por los pacientes en general para el tratamiento o la prevención de algunos trastornos o enfermedades de la piel. Reivindicación 1: Una composición farmacéutica o tópica, que comprende: (a) 0,01 - 3,0% en peso de dihidrocloruro de octenidina; (b) 1 - 20% en peso de al menos un hidrocarburo derivado del petróleo; (c) 0,5 - 10% en peso de al menos un triglicérido de ácido graso C₆₋₂₄; (d) 1 - 20 % en peso de al menos un alcohol graso C₆₋₂₄; (e) 1 - 15% en peso de al menos un tensioactivo no iónico; (f) 1 a 20% en peso de al menos un poliol; y (g) 30 - 70% en peso de agua. Reivindicación 10: Una composición según la reivindicación 1, que comprende referido al peso total de la composición: (a) 0,01 - 3,0% en peso de dihidrocloruro de octenidina; (b) 1 - 20% en peso de al menos un hidrocarburo derivado del petróleo seleccionado de parafina dura, parafina líquida, parafina líquida ligera, parafina blanda blanca y mezclas de los mismos; (c) 0,5 - 10% en peso de al menos un triglicérido de ácido graso C₆₋₂₄; (d) 1 - 20% en peso de al menos un alcohol graso C₆₋₂₄; (e) 1 - 15 % en peso de al menos un tensioactivo no iónico seleccionado de mono- y di-glicéridos, ésteres de etilenglicol o propilenglicol con ácidos grasos C₆₋₂₂, éteres alquílicos de polioxietileno, ésteres de ácidos grasos de polioxietilensorbitán, diacetato de propilenglicol, ésteres de sorbitán, y mezclas de los mismos; (f) 1 a 20% en peso de al menos un poliol seleccionado de etilenglicol, propilenglicol, 1,3-butilenglicol, 1,4-butilenglicol, hexilenglicol, dipropilenglicol, polietilenglicol con pesos moleculares medios ponderales que varían entre 100 y 1000, glicerol, poliglicerol y mezclas de los mismos; y (g) 30 - 70% en peso de agua. Reivindicación 13: Una composición de acuerdo con una cualquiera de las reivindicaciones precedentes, en donde la composición está formulada en forma de una crema, un gel, una pomada, una pasta, una suspensión, una loción, una espuma, un spray, un aerosol o una solución. Reivindicación 14: Una composición como se ha definido en una cualquiera de las reivindicaciones 1 a 13, para uso en el tratamiento o la prevención de enfermedades o trastornos de la piel seleccionados de eczema infectado (dermatitis infectada), infecciones bacterianas cutáneas o infecciones fúngicas cutáneas. Reivindicación 16: Método para tratar a un sujeto aquejado de trastornos o enfermedades de la piel definidas en la reivindicación 14, que comprende aplicar a la superficie afectada de la piel de dicho sujeto una cantidad eficaz de una composición como se ha definido en una cualquiera de las reivindicaciones 1 a 13.Pharmaceutical or cosmetic compositions are described for topical use comprising octenidine dihydrochloride. Such compositions are stable and can be applied easily and safely over large areas of the skin with good acceptance by patients in general for the treatment or prevention of some skin disorders or diseases. Claim 1: A pharmaceutical or topical composition, comprising: (a) 0.01-3.0% by weight of octenidine dihydrochloride; (b) 1-20% by weight of at least one petroleum-derived hydrocarbon; (c) 0.5-10% by weight of at least one C₆₋₂₄ fatty acid triglyceride; (d) 1-20% by weight of at least one C₆₋₂₄ fatty alcohol; (e) 1-15% by weight of at least one non-ionic surfactant; (f) 1 to 20% by weight of at least one polyol; and (g) 30-70% by weight of water. Claim 10: A composition according to claim 1, comprising referring to the total weight of the composition: (a) 0.01-3.0% by weight of octenidine dihydrochloride; (b) 1-20% by weight of at least one petroleum hydrocarbon selected from hard paraffin, liquid paraffin, light liquid paraffin, white soft paraffin and mixtures thereof; (c) 0.5-10% by weight of at least one C₆₋₂₄ fatty acid triglyceride; (d) 1-20% by weight of at least one C₆₋₂₄ fatty alcohol; (e) 1-15% by weight of at least one non-ionic surfactant selected from mono- and di-glycerides, ethylene glycol or propylene glycol esters with C₆₋₂₂ fatty acids, polyoxyethylene alkyl ethers, polyoxyethylene sorbitan fatty acid esters, diacetate of propylene glycol, sorbitan esters, and mixtures thereof; (f) 1 to 20% by weight of at least one polyol selected from ethylene glycol, propylene glycol, 1,3-butylene glycol, 1,4-butylene glycol, hexylene glycol, dipropylene glycol, polyethylene glycol with weight average molecular weights varying between 100 and 1000, glycerol , polyglycerol and mixtures thereof; and (g) 30-70% by weight of water. Claim 13: A composition according to any one of the preceding claims, wherein the composition is formulated in the form of a cream, a gel, an ointment, a paste, a suspension, a lotion, a foam, a spray, an aerosol or a solution. Claim 14: A composition as defined in any one of claims 1 to 13, for use in the treatment or prevention of diseases or disorders of the skin selected from infected eczema (infected dermatitis), bacterial skin infections or fungal skin infections . Claim 16: Method for treating a subject afflicted with skin disorders or diseases defined in claim 14, which comprises applying to the affected skin surface of said subject an effective amount of a composition as defined in any one of claims 1 to 13.

ARP140104753A 2013-12-18 2014-12-18 PHARMACEUTICAL OR COSMETIC COMPOSITIONS FOR TOPICAL USE THAT INCLUDE OCTENIDINE DIHYDROCLORIDE AR098825A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP13382521 2013-12-18

Publications (1)

Publication Number Publication Date
AR098825A1 true AR098825A1 (en) 2016-06-15

Family

ID=49876522

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP140104753A AR098825A1 (en) 2013-12-18 2014-12-18 PHARMACEUTICAL OR COSMETIC COMPOSITIONS FOR TOPICAL USE THAT INCLUDE OCTENIDINE DIHYDROCLORIDE

Country Status (4)

Country Link
EP (1) EP3082753A1 (en)
AR (1) AR098825A1 (en)
TW (1) TW201605444A (en)
WO (1) WO2015091692A1 (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10264788B2 (en) * 2015-12-30 2019-04-23 Carefusion 2200, Inc. Antimicrobial wipe
US20230060820A1 (en) * 2019-12-31 2023-03-02 3M Innovative Properties Company Octenidine salt antimicrobial medical articles
EP3981402A4 (en) * 2020-08-14 2022-08-10 BL&H Co., Ltd. Pharmaceutical composition for prevention or treatment of tinea
KR102217617B1 (en) * 2020-08-14 2021-02-19 비엘엔에이치 주식회사 Pharmaceutical composition for preventing or treating tinea
DE102020214352A1 (en) 2020-11-16 2022-05-19 Beiersdorf Aktiengesellschaft Pump spray with deodorants

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3584236D1 (en) * 1984-12-12 1991-10-31 Euro Celtique Sa ANTIBACTERIAL CREAM.
DE102005063375A1 (en) 2005-09-15 2007-04-19 Schülke & Mayr GmbH Antimicrobial preparations containing octenidine dihydrochloride encapsulated in liposomes
DE102005045145A1 (en) 2005-09-15 2007-03-29 Schülke & Mayr GmbH Use of octenidine dihydrochloride in semisolid preparations
DE102010044785A1 (en) 2010-09-09 2012-03-15 Beiersdorf Ag Octenidine dihydrochloride as a coemulsifier in microemulsions
DE102010044787A1 (en) 2010-09-09 2012-03-15 Beiersdorf Ag Macroemulsions with improved deodorant activity

Also Published As

Publication number Publication date
TW201605444A (en) 2016-02-16
WO2015091692A1 (en) 2015-06-25
EP3082753A1 (en) 2016-10-26

Similar Documents

Publication Publication Date Title
AR098825A1 (en) PHARMACEUTICAL OR COSMETIC COMPOSITIONS FOR TOPICAL USE THAT INCLUDE OCTENIDINE DIHYDROCLORIDE
BR112018011558A2 (en) composition, cosmetic use of a composition, cosmetic process for treating keratin materials and cosmetic treatment process
CL2017002432A1 (en) Composition for the treatment of hyperlipidemia comprising an oxintomodulin derivative (application divisional 0177-2015).
WO2013067271A3 (en) Stable dermatological aerosol foams utilizing reactive propellants
DOP2013000105A (en) DERIVATIVES OF 2,3-DIHYDROIMIDAZO [1,2-C] QUINAZOLINA SUBSTITUTED WITH AMINOALCOHOLES THAT ARE USEFUL TO TREAT HYPERPROLIFERATIVE DISORDERS AND DISEASES ASSOCIATED WITH ANGIOGENESIS
AR097329A1 (en) REDUCTION OF THE DERIVA DEL ROCIADO
WO2013178701A3 (en) Compositions containing fatty alcohols, cationic surfactants and n-acyl-n-methylglucamines
PE20130216A1 (en) TOPICAL FORMULATION FOR A JAK INHIBITOR
RU2016130098A (en) GEL COMPOSITIONS FOR LOCAL USE, INCLUDING POLYCAPROLACTONE POLYMER, AND WAYS TO IMPROVE LOCAL USE EFFICIENCY
AR107967A1 (en) MODIFIED Hyaluronic Acid, METHOD FOR THEIR PREPARATION AND USES OF THE SAME
AR097330A1 (en) HELPFUL COMBINATION
BR112015020049A2 (en) composition in the form of an oil-in-water emulsion and cosmetic process
PE20151759A1 (en) SUBSTITUTE IMIDAZOPYRIDAZINES
NZ735341A (en) Topical compositions comprising a corticosteroid
GB2515696A (en) Anti-adherent formulation including a quaternary ammonium compound and a fatty alcohol
JP2015534980A5 (en)
AR065317A1 (en) USE OF CHITOSANS, DERIVATIVES OF CHITOSANS AND A PHYSIOLOGICALLY ACCEPTABLE SALT OF THE SAME FOR THE TREATMENT OF UNGUE INFLAMMATORY DISEASES
DOP2016000007A (en) SUBSTITUTED PIRAZOLPIRIDINS
MX2021011424A (en) Topical formulations for delivery of hedgehog inhibitor compounds and use thereof.
RU2015116148A (en) COSMETIC BASIS FOR MAKE-UP FOR SKIN, REMOVED BY WARM WATER
MX2015003074A (en) Formulations comprising idebenone, n-acetyl-s-farnesyl-l-cysteine and ergothioneine and uses thereof.
PE20212158A1 (en) AQUEOUS PHARMACEUTICAL COMPOSITION OF ANTI-IL17A ANTIBODY AND ITS USE
CL2016002400A1 (en) Formulation for personal hygiene
AR081765A1 (en) TOPIC PHARMACEUTICAL COMPOSITIONS
PH12017500528A1 (en) External preparation composition containing s-flurbiprofen

Legal Events

Date Code Title Description
FB Suspension of granting procedure